NO920604L - Fremgangsmaate for fremstilling av naeringsmiddelinneholdende kapsler - Google Patents

Fremgangsmaate for fremstilling av naeringsmiddelinneholdende kapsler

Info

Publication number
NO920604L
NO920604L NO92920604A NO920604A NO920604L NO 920604 L NO920604 L NO 920604L NO 92920604 A NO92920604 A NO 92920604A NO 920604 A NO920604 A NO 920604A NO 920604 L NO920604 L NO 920604L
Authority
NO
Norway
Prior art keywords
fat
soluble
food
procedure
manufacture
Prior art date
Application number
NO92920604A
Other languages
English (en)
Other versions
NO920604D0 (no
NO302333B1 (no
Inventor
Michael John Story
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898918809A external-priority patent/GB8918809D0/en
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of NO920604D0 publication Critical patent/NO920604D0/no
Publication of NO920604L publication Critical patent/NO920604L/no
Publication of NO302333B1 publication Critical patent/NO302333B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
NO920604A 1989-08-17 1992-02-14 Fremgangsmåte for fremstilling av harde gelatinkapsler NO302333B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898918809A GB8918809D0 (en) 1989-08-17 1989-08-17 Pharmaceutical formulations
PCT/GB1990/001299 WO1991002520A1 (en) 1989-08-17 1990-08-17 Pharmaceutical formulations
US08/430,500 US5738871A (en) 1989-08-17 1995-04-28 Pharmaceutical formulations

Publications (3)

Publication Number Publication Date
NO920604D0 NO920604D0 (no) 1992-02-14
NO920604L true NO920604L (no) 1992-02-14
NO302333B1 NO302333B1 (no) 1998-02-23

Family

ID=26295779

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920604A NO302333B1 (no) 1989-08-17 1992-02-14 Fremgangsmåte for fremstilling av harde gelatinkapsler

Country Status (13)

Country Link
US (1) US5738871A (no)
EP (1) EP0487575B1 (no)
JP (1) JPH04507418A (no)
AT (1) ATE113471T1 (no)
AU (1) AU633959B2 (no)
CA (1) CA2063791C (no)
DE (1) DE69013923T2 (no)
DK (1) DK0487575T3 (no)
ES (1) ES2062543T3 (no)
FI (1) FI920646A0 (no)
HK (1) HK85196A (no)
NO (1) NO302333B1 (no)
WO (1) WO1991002520A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
ES2152281T3 (es) * 1993-09-28 2001-02-01 Scherer Gmbh R P Fabricacion de capsulas de gelatina blanda.
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
DK0862369T4 (da) * 1995-11-24 2009-12-14 Unilever Nv Sammensætning baseret på fiskeolie
US6056971A (en) * 1996-07-24 2000-05-02 Biosytes Usa, Inc. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AUPP022297A0 (en) 1997-11-06 1997-11-27 R.P. Scherer Holdings Pty Ltd Vitamin coating
TW367247B (en) * 1998-02-03 1999-08-21 Otsuka Pharma Co Ltd Storage container for Vitamin D solution and transfusion container
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US6346231B1 (en) * 1999-10-06 2002-02-12 Joar Opheim Flavored gelatin capsule and method of manufacture
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
GB0101198D0 (en) 2001-01-17 2001-02-28 Scherer Technologies Inc R P Ingestible compositions containing an odoriferous oil
AUPR510001A0 (en) * 2001-05-18 2001-06-14 Jupitar Pty Ltd Formulation and method
JP2005528383A (ja) * 2002-04-10 2005-09-22 ミラー，フレッド，エイチ． 多重相・複数コンパートメントカプセルシステム
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US20050215625A9 (en) * 2003-01-08 2005-09-29 Nesselroad James M Iii Combination therapy for anticoagulation
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
US20080234343A1 (en) * 2004-03-24 2008-09-25 Takeda Pharmaceutical Company Preparation with Elevated Content
AU2005329255B2 (en) 2004-04-15 2010-09-30 Chiasma, Inc. Compositions capable of facilitating penetration across a biological barrier
BRPI0515122A (pt) * 2004-08-31 2008-07-08 Akzo Nobel Nv método para solubilização de pigmento, uma composição de pigmento e seu uso
US8318196B2 (en) 2006-06-27 2012-11-27 Akzo Nobel N.V. Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations
ES2748136T3 (es) 2007-10-15 2020-03-13 United Animal Health Inc Método para aumentar el rendimiento de las crías
US8529907B2 (en) 2008-04-29 2013-09-10 Nikken Sohonsha Corporation Methods of treating ophthalmic disorders
JP6063615B2 (ja) * 2008-04-29 2017-01-18 株式会社日健総本社 眼の医学的症状の治療用組成物
CN106974888B (zh) * 2008-09-17 2019-08-02 克艾思马有限公司 药物组合物和相关的给药方法
BRPI1009431A2 (pt) 2009-03-09 2016-03-01 Pronova Biopharma Norge As pré-concentrados farmacêuticos e de suplemento alimentar, sistemas de liberação de droga, método de tratamento de pelo menos um problema de saúde em sujeito em necessidade do mesmo e método e sistema
US8197871B2 (en) * 2009-05-13 2012-06-12 L Europa Gary A Composition for headache treatment
KR102073938B1 (ko) * 2009-10-23 2020-02-05 바스프 에이에스 지방산 오일 혼합물의 코팅된 캡슐 및 정제
US10610528B2 (en) * 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
AU2011300428B2 (en) 2010-09-07 2016-03-24 Dsm Nutritional Products Ag Comestible emulsions
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US8715648B2 (en) 2011-02-16 2014-05-06 Pivotal Therapeutics Inc. Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
AU2015276321B2 (en) 2014-06-17 2019-10-24 Merck Sharp & Dohme B.V. Stable formulations of testosterone undecanoate
CA2975599A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
KR102678365B1 (ko) * 2018-03-20 2024-06-26 재단법인 경기도경제과학진흥원 콜레칼시페롤의 가용화 조성물 및 그 제조방법
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
DE102021003906B4 (de) 2021-07-30 2023-03-30 Mirco Bienhaus Verfahren und Vorrichtungen zur Herstellung fester oder halbfester Arzneiformen mit einem mehrschichtigen Aufbau

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5665820A (en) * 1979-11-02 1981-06-03 Eisai Co Ltd Hard capsule with high content of tocopherol nicotinate
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
AU561367B2 (en) * 1983-05-02 1987-05-07 Scherer, R.P. Pty. Ltd. Vitamin composition with enhanced bioavailability
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
JPH01233218A (ja) * 1988-03-15 1989-09-19 Daikyo Yakuhin Kogyo Kk ビタミン組成物
US5188688A (en) * 1990-07-20 1993-02-23 Minnesota Mining And Manufacturing Company Method of sealing a gelatin capsule
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations

Also Published As

Publication number Publication date
FI920646A7 (fi) 1992-02-14
EP0487575A1 (en) 1992-06-03
NO920604D0 (no) 1992-02-14
NO302333B1 (no) 1998-02-23
AU633959B2 (en) 1993-02-11
FI920646A0 (fi) 1992-02-14
DE69013923T2 (de) 1995-03-16
CA2063791A1 (en) 1991-02-18
WO1991002520A1 (en) 1991-03-07
CA2063791C (en) 2000-12-19
EP0487575B1 (en) 1994-11-02
ATE113471T1 (de) 1994-11-15
DK0487575T3 (da) 1994-11-28
ES2062543T3 (es) 1994-12-16
JPH04507418A (ja) 1992-12-24
HK85196A (en) 1996-05-24
US5738871A (en) 1998-04-14
DE69013923D1 (de) 1994-12-08
AU6161990A (en) 1991-04-03

Similar Documents

Publication Publication Date Title
NO920604D0 (no) Fremgangsmaate for fremstilling av naeringsmiddelinneholdende kapsler
EP0165352A3 (en) Clear micellized solutions of fat soluble essential nutrients
AR004483A1 (es) Compuestos para uso en terapia que comprenden un residuo de 1,3-propano diol como agente enlazante entre el residuo de ácido graso y un residuo bioactivo, usos de dichos compuestos y medicamentos , alimentos y formulaciones para el cuidado o tratamiento de la piel que comprenden a dichos compuestos
ES2052645T3 (es) Acidos poliinsaturados con accion vasocinetica y formulaciones farmaceuticas y cosmeticas que los contienen.
ES534598A0 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
ATE236627T1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
BR9713462A (pt) Métodos para produção de compostos carotenóides e óleos especiais em sementes de plantas.
MY104412A (en) Acne treatment.
GR3001312T3 (en) Pharmaceutical composition containing 2-(2-fluoro-4-biphenylyl)propionic acid or a salt thereof
Osborn-Barnes et al. Effects of α-tocopherol, β-carotene, and soy isoflavones on lipid oxidation of structured lipid-based emulsions
YU17899A (sh) Farmaceutske mikrosfere valproinske kiseline za oralnu upotrebu
RU98115892A (ru) Фармацевтическая композиция, содержащая циклоспорин, способ получения мягких желатиновых капсул, способ лечения
DK206387D0 (da) Anvendelse af glucofurol til flydende-goeren af laegemiddelpraeparater til fyldning i bloede gelatinkapsler
ATE75395T1 (de) Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.
AR016629A1 (es) Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica.
ES8600003A1 (es) Procedimiento para la produccion de callo de girasol
YU49404B (sh) Nova smesa koja sadrži ciklosporin i poboljšani postupak za dobijanje mekih želatinskih kapsula koje sadrže ciklosporin
GB1516489A (en) Glyceride liquid nutriment composition
JPS5511526A (en) Cosmetic
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ES2187668T3 (es) Formulacion de oxido de 1,2,4-benzotriazina en capsulas de gel oral es.
MX9305997A (es) 6-heterociclic-4-amino-1, 2, 2a, 3, 4, 5-hexahidrobenz[cd]indoles yprocedimiento para su preparacion.
JPS5764609A (en) Cyclophosphamide composition for rectal administration
ES2125935T3 (es) Derivados fosfolipidicos que contienen elementos superiores del quinto grupo principal.
GB1133845A (en) Pharmaceutical compositions comprising dextran and cellulose ethers